sapiencetherapeutics.comHealthcareFounded: 2015Funding to Date: $63.88MM
Sapience Therapeutics develops peptide-based oncology treatments and therapies by targeting intracellular interactions.
For more details on financing and valuation for Sapience Therapeutics, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Sapience Therapeutics.
To read this article and more news on Sapience Therapeutics, register or login.
